In the 5th edition of the WHO Classification of Female Genital Tumors, four distinct molecular subtypes of endometrial carcinoma are now recognized: POLE-ultramutated, mismatch repair-deficient (MMRd), p53-mutant, and tumors without a specific molecular profile. Here, TP53 is linked to endometrial carcinoma.